IS5482A - Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia - Google Patents

Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia

Info

Publication number
IS5482A
IS5482A IS5482A IS5482A IS5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A
Authority
IS
Iceland
Prior art keywords
dementia
tetrahydropyridine
alzheimer
treatment
composition
Prior art date
Application number
IS5482A
Other languages
Icelandic (is)
Inventor
Maffrand Jean-Pierre
Soubrie Philippe
Terranova Jean-Paul
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/en
Priority claimed from FR9714322A external-priority patent/FR2771007B1/en
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS5482A publication Critical patent/IS5482A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS5482A 1997-11-14 2000-05-09 Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia IS5482A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FR9714322A FR2771007B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
PCT/FR1998/002384 WO1999025363A1 (en) 1997-11-14 1998-11-09 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia

Publications (1)

Publication Number Publication Date
IS5482A true IS5482A (en) 2000-05-09

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5482A IS5482A (en) 1997-11-14 2000-05-09 Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia

Country Status (27)

Country Link
EP (1) EP1030671A1 (en)
JP (1) JP2001523642A (en)
KR (1) KR100599350B1 (en)
CN (1) CN1243540C (en)
AU (1) AU743228B2 (en)
BG (1) BG64819B1 (en)
BR (1) BR9814035A (en)
CA (1) CA2309966A1 (en)
CO (1) CO4980891A1 (en)
DZ (1) DZ2649A1 (en)
EA (1) EA003255B1 (en)
EE (1) EE04235B1 (en)
HU (1) HUP0100098A3 (en)
ID (1) ID24933A (en)
IL (2) IL136122A0 (en)
IS (1) IS5482A (en)
MY (1) MY120461A (en)
NO (1) NO20002450L (en)
NZ (1) NZ504420A (en)
OA (1) OA11464A (en)
PL (1) PL194597B1 (en)
SA (1) SA98190747B1 (en)
SK (1) SK286040B6 (en)
TR (1) TR200001262T2 (en)
TW (1) TW585766B (en)
UY (1) UY25247A1 (en)
WO (1) WO1999025363A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE42327E1 (en) 2002-06-14 2011-05-03 Toyama Chemical Co., Ltd. Medicinal compositions improving brain function and method for improving brain function
DK1529116T3 (en) * 2002-08-07 2009-11-09 Novartis Ag Method for predicting response to rivastigmine treatment based on the ApoE genotype in dementia patients
CN1520818A (en) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 Cholinesterase inhibitor pharmaceutical composition for senile dementia
AU2005320547B2 (en) 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
DK3099296T3 (en) 2014-01-31 2019-04-15 Cognition Therapeutics Inc ISO-INDOLINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
IL270251B2 (en) * 2017-05-15 2025-01-01 Cognition Therapeutics Inc 1-phenyl-1,1-dimethyl-2-(piperidinyl/pyrrolidinyl/piperazinyl)-ethane derivatives and pharmaceutical compositions comprising them
KR102224917B1 (en) 2018-03-20 2021-03-09 (주)인벤티지랩 Production methods of preventing or treating cognitive impairment-related disease and preventing or treating cognitive impairment-related disease producing thereto
WO2019182319A1 (en) * 2018-03-20 2019-09-26 (주)인벤티지랩 Method for preparing pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, and pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, prepared by preparation method
CN109265391B (en) * 2018-11-13 2021-11-19 枣庄学院 Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (en) * 1990-05-22 1994-11-10 Sanofi Sa USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
EP0813416B1 (en) * 1995-03-06 2005-05-25 Interneuron Pharmaceuticals Incorporated Reduction of infarct volume using citicoline
FR2736053B1 (en) * 1995-06-28 1997-09-19 Sanofi Sa NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES

Also Published As

Publication number Publication date
JP2001523642A (en) 2001-11-27
PL340500A1 (en) 2001-02-12
ID24933A (en) 2000-08-31
EP1030671A1 (en) 2000-08-30
DZ2649A1 (en) 2004-12-28
NO20002450L (en) 2000-07-14
PL194597B1 (en) 2007-06-29
EA200000412A1 (en) 2000-12-25
CA2309966A1 (en) 1999-05-27
CN1285742A (en) 2001-02-28
HUP0100098A3 (en) 2001-12-28
EA003255B1 (en) 2003-02-27
SK7112000A3 (en) 2000-10-09
KR20010032099A (en) 2001-04-16
EE200000290A (en) 2001-06-15
CN1243540C (en) 2006-03-01
CO4980891A1 (en) 2000-11-27
KR100599350B1 (en) 2006-07-12
IL136122A0 (en) 2001-05-20
BG104428A (en) 2001-08-31
BG64819B1 (en) 2006-05-31
IL136122A (en) 2006-07-05
AU743228B2 (en) 2002-01-24
SK286040B6 (en) 2008-01-07
HUP0100098A2 (en) 2001-07-30
UY25247A1 (en) 2001-05-31
NZ504420A (en) 2003-08-29
SA98190747B1 (en) 2006-11-04
WO1999025363A1 (en) 1999-05-27
TW585766B (en) 2004-05-01
EE04235B1 (en) 2004-02-16
BR9814035A (en) 2000-09-26
MY120461A (en) 2005-10-31
NO20002450D0 (en) 2000-05-11
AU1160999A (en) 1999-06-07
TR200001262T2 (en) 2001-01-22
OA11464A (en) 2003-11-18

Similar Documents

Publication Publication Date Title
DK1123313T3 (en) Methods and compositions for the prevention and treatment of anemia
DE69612185D1 (en) BLEACHING METHOD AND BLENDER COMPOSITION
DE69739583D1 (en) TOPICAL COMPOSITIONS CONTAIN AS A THERAPEUTICALLY ACTIVE AGENT A MONOGLYCERIDE FOR THE TREATMENT OF SLEW-TONE INFECTIONS
DE69728594D1 (en) Chromium-free composition for the treatment of metal surfaces
DK0622408T3 (en) Composition and process for the preparation of gelatin-free soft capsules
DE69638351D1 (en) AS WELL AS FOR RESISTING THE DISTAL AND FRONT FEMUR
DE69413051D1 (en) DETERGENT COMPOSITIONS CONTAINING AGENTS FOR PREVENTING THE TURNING OF SILVER
DE69718668D1 (en) LIQUID COMPOSITION, INCLUDING HIV PROTEASE INHIBITORS AND C12-C18 FATTY ACID
DE69617088D1 (en) Process for the preparation of crystallized maltitol and crystallines containing it.
DE69812784D1 (en) Composition for the prevention and elimination of plant diseases
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
NO20012963L (en) Process for the preparation of 3-alkanoylindoles and 3-alkylindoles
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
IS5482A (en) Composition of active ingredients especially of tetrahydropyridine and acetylcholine esterase inhibitory agent for the treatment of dementia such as Alzheimer's dementia
DE69831788D1 (en) Process for the preparation of semi-transparent mixtures of poly-phenyleoxides and styrenic copolymers
DE69420229D1 (en) Pharmaceutical composition for the treatment of AIDS
NO992504L (en) Compositions for the treatment of soil, process for its preparation, and use
DK1007040T3 (en) The use of phanquinone in the treatment of Alzheimer's disease
NO20001758D0 (en) Methods and compositions for the treatment of arthritis
DK0918521T3 (en) Formulation for the treatment and / or prevention of dementia
DE69802498D1 (en) COMBINATION PRODUCT CONTAINING IDEBENON FOR ALZHEIMER TREATMENT
WO2000033788A3 (en) Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
NO20012099D0 (en) Process for the preparation of 4-arylpiperidine-3-carbinols and related compounds
EP0635567A3 (en) Method and composition for facilitating the removal of soil contaminants from solid surfaces.
FI944687A7 (en) Composition for the prevention and treatment of myopia